Although dopaminergic medication may also improve sleep quality by reducing sleep onset latency (the time taken to fall asleep) and wakefulness in PD patients, there are documented reports of ...

Medications enhancing dopaminergic tone include amantadine, bupropion, and stimulants, with yohimbine showing noradrenergic effects. Among the reported antidotes, the only 2 without ...

It could be due to or be exacerbated by PD treatment and, vice versa, it could determine an alteration in the pharmacokinetic of dopaminergic medications. Patients should be counseled on the ...

with or without dopaminergic medications. Amantadine has been approved since the 1970s to treat Parkinson’s but Adamas has produced it in an extended release formulation to allow for a gradual ...

8 Box 1 provides a summary of the PD medications that could confound the results of biochemical tests for pheochromocytoma. Patients with PD might have to be taken off their dopaminergic ...

This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...